Aerie Pharmaceuticals Research Coverage Started at JMP Securities (AERI)

September 13, 2015
JMP Securities began coverage on shares of Aerie Pharmaceuticals (NASDAQ:AERI) in a research report issued on Wednesday, The Fly reports. The firm set an “outperform” rating and a $39.00 price target on the stock. JMP Securities’ price objective points to a potential upside of 112.07% from the company’s current price. Aerie Pharmaceuticals (NASDAQ:AERI) traded up […]
Read more at:http://www.americanbankingnews.com/2015/09/12/aerie-pharmaceuticals-research-coverage-started-at-jmp-securities-aeri/

Site Created by finaceandbankingnewsnow.com